 |
市場調査レポート
商品コード
1111783
パニック障害の臨床試験市場：試験の相別、試験状況別、試験回数別、エンドポイント別、ステータス別、スポンサータイプ別、上位国別分析、2022年最新版Panic Disorders Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update |
||||||
● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。 詳細はお問い合わせください。
価格
| パニック障害の臨床試験市場：試験の相別、試験状況別、試験回数別、エンドポイント別、ステータス別、スポンサータイプ別、上位国別分析、2022年最新版 |
|
出版日: 2022年06月28日
発行: GlobalData
ページ情報: 英文 217 Pages
納期: 即納可能
|
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
- 全表示
- 概要
- 図表
- 目次
概要
当レポートでは、世界のパニック障害の臨床試験市場について調査し、市場の概要とともに、試験の相別、試験状況別、試験回数別、エンドポイント別、ステータス別、スポンサータイプ別、上位国別の最新動向などを提供しています。
目次
- 報告ガイダンス
- 臨床試験調査範囲
- 地域別の臨床試験
- 国別の臨床試験と平均登録者数
- G7諸国における臨床試験：中枢神経系の臨床試験に対するパニック障害の割合
- G7諸国における相別の臨床試験
- G7諸国における治験状況別の臨床試験
- E7諸国における臨床試験：中枢神経系の臨床試験に対するパニック障害の割合
- E7諸国における相別の臨床試験
- E7諸国における治験状況別の臨床試験
- 相別の臨床試験
- 相別の進行中試験
- 治験状況別の臨床試験
- エンドポイントステータス別の臨床試験
- 一定期間にわたって採用された被験者
- スポンサータイプ別の臨床試験
- 著名なスポンサー
- パニック障害治療薬の臨床試験に参加している主要企業
- 著名な薬剤
- 臨床試験プロファイルのスナップショット
付録
- 略語
- 定義
- 調査手法
- 2次調査
- GlobalDataについて
- お問合せ
- ソース
図表
List of Tables
List of Tables
- Panic Disorders Therapeutics, Global, Clinical Trials by Region, 2022*
- Panic Disorders Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2022*
- Panic Disorders Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2022*
- Panic Disorders Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2022*
- Panic Disorders Therapeutics Clinical Trials, Europe, Top Five Countries, 2022*
- Panic Disorders Therapeutics Clinical Trials, North America, Top Countries, 2022*
- Panic Disorders Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2022*
- Panic Disorders Therapeutics Clinical Trials, Central and South America, Top Countries, 2022*
- Proportion of Panic Disorders to Central Nervous System Clinical Trials, G7 Countries (%), 2022*
- Panic Disorders Therapeutics, G7 Countries, Clinical Trials by Phase, 2022*
- Panic Disorders Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2022*
- Proportion of Panic Disorders to Central Nervous System Clinical Trials, E7 Countries (%), 2022*
- Panic Disorders Therapeutics, E7 Countries, Clinical Trials by Phase, 2022*
- Panic Disorders Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2022*
- Panic Disorders Therapeutics, Global, Clinical Trials by Phase, 2022*
- Panic Disorders Therapeutics, Global, Clinical Trials In Progress by Phase 2022*
- Panic Disorders Therapeutics, Global, Clinical Trials by Trial Status, 2022*
- Panic Disorders Therapeutics Clinical Trials, Global, by End Point Status, 2022*
- Panic Disorders Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2017-2021
- Panic Disorders Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2022*
- Panic Disorders Therapeutics Clinical Trials, Global, Key Sponsors, 2022*
- Panic Disorders Therapeutics Clinical Trials, Global, Top Companies by Phase, 2022*
- Panic Disorders Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2022*
List of Figures
List of Figures
- Panic Disorders Therapeutics, Global, Clinical Trials by Region (%), 2022*
- Panic Disorders Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2022*
- Panic Disorders Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2022*
- Panic Disorders Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2022*
- Panic Disorders Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2022*
- Panic Disorders Therapeutics Clinical Trials, North America, Top Countries (%), 2022*
- Panic Disorders Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2022*
- Panic Disorders Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2022*
- Proportion of Panic Disorders to Central Nervous System Clinical Trials, G7 Countries (%), 2022*
- Panic Disorders Therapeutics, G7 Countries, Clinical Trials by Phase, 2022*
- Panic Disorders Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2022*
- Proportion of Panic Disorders to Central Nervous System Clinical Trials, E7 Countries (%), 2022*
- Panic Disorders Therapeutics, E7 Countries, Clinical Trials by Phase, 2022*
- Panic Disorders Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2022*
- Panic Disorders Therapeutics, Global, Clinical Trials by Phase (%), 2022*
- Panic Disorders Therapeutics, Global, Clinical Trials In Progress by Phase, 2022*
- Panic Disorders Therapeutics, Global, Clinical Trials by Trial Status, 2022*
- Panic Disorders Therapeutics Clinical Trials, Global, by End Point Status, 2022*
- Panic Disorders Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2017-2021
- Panic Disorders Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2022*
- Panic Disorders Therapeutics Clinical Trials, Global, Key Sponsors, 2022*
- Panic Disorders Therapeutics Clinical Trials, Global, Top Companies by Phase, 2022*
- Panic Disorders Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2022*
- GlobalData Methodology
目次
Product Code: GDHC6898CTIDB
GlobalData's clinical trial report, "Panic Disorders - Global Clinical Trials Review, 2022" provides an overview of Panic Disorders Clinical trials scenario. This report provides top line data relating to the clinical trials on Panic Disorders. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma - Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.
The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Reasons to Buy
- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Table of Contents
Table of Contents
- Report Guidance
- GlobalData Clinical Trials Report Coverage
- Clinical Trials by Region
- Clinical Trials and Average Enrollment by Country
- Clinical Trials by G7 Countries: Proportion of Panic Disorders to Central Nervous System Clinical Trials
- Clinical Trials by Phase in G7 Countries
- Clinical Trials in G7 Countries by Trial Status
- Clinical Trials by E7 Countries: Proportion of Panic Disorders to Central Nervous System Clinical Trials
- Clinical Trials by Phase in E7 Countries
- Clinical Trials in E7 Countries by Trial Status
- Clinical Trials by Phase
- In Progress Trials by Phase
- Clinical Trials by Trial Status
- Clinical Trials by End Point Status
- Subjects Recruited Over a Period of Time
- Clinical Trials by Sponsor Type
- Prominent Sponsors
- Top Companies Participating in Panic Disorders Therapeutics Clinical Trials
- Prominent Drugs
- Clinical Trial Profile Snapshots
Appendix
- Abbreviations
- Definitions
- Research Methodology
- Secondary Research
- About GlobalData
- Contact Us
- Source
